The purchase of NPS is bizarre, 'short bowel syndrome' ?
How about human suffering from BRAIN disorders ?
Alkermes is based in Ireland, already, maybe this whole thing is a tax plot for NPS long time holders?
@@@@@While Shire needs to focus first on completing the NPS deal, “given the amount of cash we generate and our ability to take on further debt, this does not put any restrictions of significance on our strategy to become a leader in the biotech area,” Ornskov said in the interview. “Obviously that will require further M&A.” Acquisitions work best when they’re in a disease area “you know very well,” he said, which for Shire includes rare diseases, gastrointestinal diseases, and opthalmology, he said.
And there it is. ~50% premium to the price before the latest round of rumors broke out is inline with SHPG's other recent acquisition VPHM. If the FDA approves Natpara without any significant restrictions we should get a nice pop.
@@@@@LONDON (Reuters) - Shire Plc (SHP.L) has agreed to buy NPS Pharmaceuticals Inc (NPSP.O) for $5.2 billion in its biggest acquisition yet, as the Dublin-based drugmaker strengthens its position in the lucrative field of medicines for rare diseases.